Inaktiver Wert

Biondvax Pharmaceuticals Ltd Aktie Other OTC

Aktien

Dauer

Zeitraum

Stil

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	16.07.19
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	08.07.19
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	26.06.19
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	18.06.19
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	10.06.19

Sektor

	% 1. Jan.	Kap.
MODERNA, INC.	+64,23 %	62,59 Mrd.
IQVIA HOLDINGS INC.	-2,31 %	41,18 Mrd.
LONZA GROUP AG	+44,87 %	40,29 Mrd.
CELLTRION, INC.	-8,29 %	27,9 Mrd.
ICON PUBLIC LIMITED COMPANY	+11,97 %	26,21 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-21,16 %	19,09 Mrd.
BIO-TECHNE CORPORATION	+7,54 %	13,08 Mrd.
MEDPACE HOLDINGS, INC.	+27,17 %	12,05 Mrd.
UNITED THERAPEUTICS CORPORATION	+25,72 %	12,26 Mrd.